The Potential Hazards of E-Cigarette and Dual Use: a Cochrane Systematic Review and Secondary Analysis

Dec.01.2022
The Potential Hazards of E-Cigarette and Dual Use: a Cochrane Systematic Review and Secondary Analysis
A study on Cochrane's systematic review found that switching from smoking to e-cigarettes significantly reduces potential harm biomarkers. However, a separate study found that using both traditional and e-cigarettes has the same harmful effect on the heart as smoking alone.

Title: Biomarkers of potential harm from switching from tobacco smoking to e-cigarette use, dual use or cessation: a Cochrane systematic review and meta-analysis of secondary analysis of data from randomized controlled trials of electronic cigarettes for smoking cessation. In this study, researchers conducted a secondary analysis of data from randomized controlled trials of electronic cigarettes for smoking cessation in Greece, Italy, Poland, the United Kingdom, and the United States. The conclusion drawn was that switching from tobacco smoking to e-cigarette use significantly lowered potential harmful biomarkers.


At the same time, according to a recent study published in the American Heart Association journal "Circulation," using both traditional cigarettes and e-cigarettes poses the same risk to the heart as smoking alone.


A study titled "Association Between Patterns of Cigarette and E-Cigarette Use and Inflammatory and Oxidative Stress Biomarker Levels in U.S. Adults: A Population Assessment of Tobacco and Health Study" analyzed more than 7,100 U.S. adults aged 18 and over to explore the connection between smoking, vaping, and heart health.


Researchers used data from the Population Assessment of Tobacco and Health (PATH) study to search for biomarkers of inflammation and oxidative stress, as these biomarkers are known to indicate predictive factors for heart disease and cardiovascular events, such as heart attacks and heart failure.


After analyzing five biomarkers of inflammation and oxidative stress, participants were divided into four groups: exclusive smokers, exclusive e-cigarette users, dual users, and non-users of e-cigarettes. Researchers listed the following findings:


Participants who only use electronic cigarettes showed similar levels of inflammation and oxidative stress as those who do not use electronic cigarettes or smoke at all. However, compared to participants who do not use cigarettes or electronic cigarettes, those who smoke exclusively or use both cigarettes and electronic cigarettes had higher levels of all evaluated biomarkers. Participants who only use electronic cigarettes had significantly lower levels of nearly all inflammation and oxidative stress biomarkers compared to those who only smoke. However, participants who use both cigarettes and electronic cigarettes had biomarker levels similar to those who exclusively smoke. 2FIRSTS will continue to report on this issue, with updates available on the "2FIRSTSAPP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.
Aug.22 by 2FIRSTS.ai
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
2Firsts Interview | Sneak Peek: Westfallenhallen’s Sabine Loos Reveals What Visitors Can Expect at InterTabac 2025
As an official media partner of InterTabac, 2Firsts spoke exclusively with Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, to preview the 45th edition of the event. This year’s InterTabac and InterSupply will feature 11 halls, over 800 exhibitors, dozens of forums, and major product debuts. The interview explores trends in NGPs, oral nicotine, hybrid formats, and global regulatory topics—offering a comprehensive look into innovation and industry dialogue.
Aug.06
Product | Clear Tank + 40,000 Puffs: EBCREATE BC PRO 40K Launches in the U.S.
Product | Clear Tank + 40,000 Puffs: EBCREATE BC PRO 40K Launches in the U.S.
EBCREATE BC PRO 40K disposable e-cigarette with Clear Tank design hits US market at $24.99.
Aug.13 by 2FIRSTS.ai
2FIRSTS成为InterTabac官方媒体合作伙伴,提供定制品牌传播资源。
2FIRSTS成为InterTabac官方媒体合作伙伴,提供定制品牌传播资源。
2FIRSTS reestablished as official media partner for InterTabac 2025, offering tailored global brand exposure packages for tobacco industry exhibitors.
Aug.06 by 2FIRSTS.ai
Product | Reaching 60,000 Puffs, Innokin Launches MVP 60K Kit in the UK
Product | Reaching 60,000 Puffs, Innokin Launches MVP 60K Kit in the UK
INNOKIN has recently launched the MVP 60K vape kit in the UK market. The kit includes a 1000mAh built-in battery and three "2+10" combo pods. The company claims a total of 60,000 puffs, and the product offers 9 different flavor combinations. The MVP 60K has been registered in the database of the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and is now available on the websites of several UK distributors.
Aug.21 by 2FIRSTS.ai
Vapesourcing, a leading U.S. vape retailer, has announced it will no longer supply flavored nicotine products to California and Massachusetts.
Vapesourcing, a leading U.S. vape retailer, has announced it will no longer supply flavored nicotine products to California and Massachusetts.
Due to local regulations, leading U.S. vape retailer Vape Sourcing has stopped shipping flavored nicotine products to California and Massachusetts. This is because California is implementing a "flavor ban," while Massachusetts already banned flavored tobacco and vapes in 2019. Customers in these states can still buy unflavored or non-nicotine products.
Aug.22 by 2FIRSTS.ai